Results 21 to 30 of about 16,400 (171)

On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty [PDF]

, 2022
Altres ajuts: acords transformatius de la UABBackground. Nucleos(t)ide analogues withdrawal may improve HBsAg loss rates. However, conditions to select patients are not well established.Aims to evaluate the impact of HBsAg kinetics before treatment ...
Broquetas, Teresa, Mico, Miquel, Viu, Ana, Carrión Rodríguez, José Antonio, García Retortillo, Montserrat, Garcia-Retortillo, M, Coll, Susanna, Bessa Caserras, Xavier, Hernández, Juan José, Cañete Hidalgo, Nuria, Puigvehí, Marc, Canillas, Lidia, Coll Estrada, Susanna, Garrido, Esther, Hernandez, Juan-Jose   +14 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of HBsAg in Chronic Hepatitis B Patients with High HBsAg Levels

, 2023
Background & aims: Seroclearance of hepatitis B surface antigen (HBsAg) indicates functional cure for hepatitis B virus (HBV) infection. Low HBsAg levels can predict HBsAg seroclearance over time.
Tai-Chung Tseng; Chieh Chiang; Chun-Jen Liu; Chun-Ming Hong; Tung-Hung Su; Hung-Chih Yang; Wan-Ting Yang; Chen-Hua Liu; Pei-Jer Chen; Jia-Horng Kao
core   +1 more source

Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion. [PDF]

Viruses, 2019
: It is well appreciated that ethnicity influences the natural history and immune responses during a chronic hepatitis B infection. In this study, we explore the effect of ethnicity and treatment cessation on Hepatitis B surface Antigen (HBsAg ...
Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen H, Vanwolleghem T.   +12 more
europepmc   +4 more sources

Regression of liver fibrosis after HBsAg loss: A prospective matched case-control evaluation using transient elastography and serum enhanced liver fibrosis test. [PDF]

J Gastroenterol Hepatol
Background and Aim: We assessed the effect of hepatitis B surface antigen (HBsAg) seroclearance (HBsAg-loss) on liver fibrosis regression in patients with chronic hepatitis B (CHB) infection.
Mak LY, Hui RW, Chung MSH, Wong DK, Fung J, Seto WK, Yuen MF.   +6 more
europepmc   +2 more sources

Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels

, 2022
BACKGROUND AND AIMS: Current guidelines recommend long-term nucleot(s)ide analogue (NA) therapy for patients with HBeAg-negative chronic hepatitis B (CHB).
Lubel, JS, Jackson, K, Visvanathan, K, Locarnini, SA, Strasser, SI, Angus, P, Hall, SAL, Ngu, MC, Meredith, C, Thompson, A, Nicoll, A, Matthews, G, Sievert, W, Desmond, PV, Vogrin, S, Littlejohn, M, Sinclair, M, Ratnam, D, Burns, GS, Sundararajan, V, Revill, PA, Anagnostou, D, Bowden, D, Levy, MT   +23 more
core   +2 more sources

Acute delta superinfection in a previously unrecognised HBsAg carrier with transient loss of HBsAg simulating acute non-A, non-B hepatitis. [PDF]

Gut, 1988
An 18 yr old previously well male Taiwanese was admitted with malaise, anorexia, and jaundice for two weeks. Results of liver tests were compatible with acute hepatitis. On day 1, he was seronegative for HBsAg, IgM anti-HAV, IgM anti-HBc, IgM anti-CMV, and IgM EBV capsid Ab, but positive for anti-delta in association with anti-HBc and anti-HBs.
C M, Chu, Y F, Liaw
openaire   +2 more sources

“Nature's Polymer Reimagined: Conventional and Green Routes to Pectin, Its Bioactive Promise and Industrial Applications”

Food Chemistry International, EarlyView.
Pectin, a versatile natural polymer, is extracted through conventional and emerging green extraction methods, offering multifunctional bioactive properties useful in food, pharmaceutical, and environmental applications. ABSTRACT Pectin, a molecular tapestry woven from diverse polysaccharides, holds a pivotal role across food, pharmaceutical, and ...
Afra Anika Rafique, Aunwesha Sahani, Md Morsaline Billah, Kazi Mohammed Didarul Islam   +3 more
wiley   +1 more source

Prediction time (years) to HBsAg loss during ADV/ETV treatment.

, 2014
Scatter diagrams displaying the changes in HBsAg levels during therapy and the median levels of HBsAg at each time-point, linear equation calculated by interpolating the median logarithmic decline over time extrapolating the treatment duration required ...
Fang Li (41162), Feng-Qin Hou (573855), Xia-Xia Zhang (573857), Qin-Huan Wang (573854), Na Huo (573856), Hong-Li Xi (524523), Min-Ran Li (573853), Xiao-Yuan Xu (524524)   +7 more
core   +1 more source

Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy. [PDF]

BACKGROUND We evaluated long-term trajectories of circulating hepatitis B virus (HBV)-RNA and hepatitis B core-related antigen (HBcrAg) in persons with and without hepatitis B surface antigen (HBsAg) loss during tenofovir therapy in the Swiss HIV ...
Swiss HIV Cohort Study, Testoni, Barbara, Schmid, Patrick, Günthard, Huldrych F, Zoulim, Fabien, Levrero, Massimo, Salazar-Vizcaya, Luisa, Begré, Lorin, Rauch, Andri, Rockstroh, Jürgen K, Wandeler, Gilles, Hirsch, Hans H, Béguelin, Charles, Boyd, Anders, Scholtès, Caroline, Plissonnier, Marie-Laure, Calmy, Alexandra, Suter-Riniker, Franziska, Cavassini, Matthias, Bernasconi, Enos   +19 more
core   +1 more source